Our findings could have clinical implications, both to improve prediction of effects of TNF-α-inhibition in RA and to improve prediction of outcome in order to optimize therapy, because one of the problems is the difficulty to identify non-responders before treatment. Here, TNF is linked to rheumatoid arthritis.